The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
10.1007/s13238-017-0441-3
- Author:
Shilei ZHANG
1
;
Deng PAN
2
;
Xin-Ming JIA
1
;
Xin LIN
3
;
Xueqiang ZHAO
4
Author Information
1. Department of Immunology, Tongji University School of Medicine, Shanghai, 200092, China.
2. Cancer Biology Program, Graduate School of Biomedical Sciences, The University of Texas, Houston, TX, 77030, USA.
3. Department of Basic Medical Sciences, Tsinghua University School of Medicine, Beijing, 100084, China. linxin307@tsinghua.edu.cn.
4. Department of Basic Medical Sciences, Tsinghua University School of Medicine, Beijing, 100084, China. zhaoxueqiang@mail.tsinghua.edu.cn.
- Publication Type:Letter
- MeSH:
Animals;
Antineoplastic Agents;
pharmacology;
B-Cell CLL-Lymphoma 10 Protein;
deficiency;
metabolism;
CARD Signaling Adaptor Proteins;
deficiency;
metabolism;
Cell Survival;
drug effects;
DNA Damage;
Doxorubicin;
pharmacology;
HeLa Cells;
Humans;
Mice;
Mice, Knockout;
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein;
deficiency;
metabolism;
NF-kappa B;
metabolism
- From:
Protein & Cell
2017;8(11):856-860
- CountryChina
- Language:English
